Almond (Prunus dulcis)
Almonds are the edible seeds of Prunus dulcis, eaten whole and sold as almond flour (ground almonds), almond butter and almond protein. Per 100 g, USDA lists about 50 g of fat, mostly monounsaturated, plus 21 g of protein, 12.5 g of fiber and 25.6 mg of vitamin E. Pooled trials found small drops in LDL cholesterol and diastolic blood pressure, and FDA will consider enforcement discretion for a qualified claim for eating 1.5 ounces a day of most nuts as part of a diet low in saturated fat and cholesterol. Against snacks of equal calories, almonds did not change body weight, a working memory trial found no change, and pooled trials found no effect on fasting blood sugar. Small trials reported fewer facial wrinkles in postmenopausal women and less muscle pain after downhill running. Most trials were funded by the almond industry. Almonds are a tree nut, one of the nine major US food allergens.
Benefits
Diastolic blood pressure and the FDA qualified claim for nuts
A pooled analysis of 16 randomized trials (1,128 people) found diastolic pressure 1.30 mmHg lower with almonds, while systolic pressure did not change significantly. A 6 week calorie-matched trial in 107 adults found no blood pressure difference. FDA will consider enforcement discretion for a qualified claim that evidence suggests but does not prove that 1.5 ounces a day of most nuts, in a diet low in saturated fat and cholesterol, may reduce heart disease risk.
LDL cholesterol and ApoB, blood lipid markers
Pooling 48 comparisons of almonds against nut-free controls (2,485 adults), almonds lowered LDL cholesterol by 0.13 mmol/L, total cholesterol by 0.16 mmol/L and ApoB by 4.6 mg/dL, while HDL cholesterol and Lp(a) did not change. In a 6 week trial, almond snacks lowered LDL by 0.25 mmol/L more than matched snacks. The pooled analysis was industry funded.
Blood vessel function when almonds replace usual snacks
In 107 adults at above-average cardiovascular risk, whole almonds providing 20 percent of energy for 6 weeks raised flow-mediated dilation, a primary outcome, by 4.1 percentage units more than calorie-matched snacks. Liver fat, the other primary outcome, and blood pressure, triglycerides and glucose did not differ. The trial was funded by the almond industry.
Facial wrinkles in postmenopausal women
In a small trial in 28 postmenopausal women with fair skin, almonds providing 20 percent of energy for 16 weeks were reported to leave wrinkle severity and width 9 and 10 percent lower than a calorie-matched snack, but the registered primary outcome, wrinkle depth, was not reported. A 24 week follow-up in 49 women reported only changes from baseline. Both trials were funded at least in part by the almond industry.
Muscle pain and strength after downhill running
In a crossover trial in 26 adults, 2 ounces of almonds a day for 8 weeks, against calorie-matched pretzels, lowered pain during maximal contraction 24 and 48 hours after a downhill run and kept more leg flexion strength. Vertical jump, C-reactive protein and myoglobin did not differ. The registered primary outcomes were not reported, and the almond industry funded the study.
Body weight against calorie-matched snacks
On a 30 percent reduced-calorie diet, 140 adults lost 7.0 kg on average whether their snacks were almonds or carbohydrate-rich foods, so almonds neither added nor slowed weight loss. A pooled analysis of 37 trials found 0.45 kg less weight with almonds overall; by subgroup, weight fell in trials against nut-free diets but not in trials against other snacks or nuts.
Fasting blood sugar and HbA1c, blood sugar markers
A pooled analysis of 24 studies (31 arms) found no significant change in fasting blood sugar, HbA1c, insulin or insulin resistance with almonds. In a 12 week trial in older adults, almonds did not change glucose or insulin compared with calorie-matched snacks, and in a reduced-calorie diet trial glucose improved equally with or without almonds.
Mechanism of action
Unsaturated fat, fiber and vitamin E
Per 100 g, almonds supply about 32 g of monounsaturated and 12 g of polyunsaturated fat against 4 g of saturated fat, plus 12.5 g of fiber and 25.6 mg of vitamin E. Researchers propose that eating almonds in place of carbohydrate-rich snacks shifts the diet toward unsaturated fat and fiber, which would fit the small LDL and ApoB changes. This has not been isolated in trials.
Cell walls that hold back fat
Much of the fat in almonds stays inside intact plant cells after chewing. In a mastication study, the predicted share of fat released was about 9.3 percent for whole almonds and 10.4 percent for ground almonds, a small but significant difference that did not change any gut or microbiota outcome in the matching 4 week trial.
Fiber fermentation in the gut
Almond fiber reaches the colon, where bacteria ferment it. In a 4 week trial, 56 g a day of almonds raised fecal butyrate, a short-chain fatty acid, compared with a calorie-matched muffin, but did not change bifidobacteria (the primary outcome), overall microbiota diversity or gut transit time.
Clinical trials
Randomized, controlled parallel trial after a 2 week run-in; whole roasted almonds or control snacks matching average UK snack macronutrients, each providing 20 percent of energy needs, for 6 weeks; flow-mediated dilation and liver fat were the primary outcomes; registered NCT02907684; funded by the Almond Board of California and the Indonesia Endowment Fund for Education (Dikariyanto et al. 2020, Am J Clin Nutr)
107 adults aged 30 to 70 at above-average cardiovascular risk; 51 received almonds and 56 control snacks.
Flow-mediated dilation rose more with almonds (mean difference 4.1 percentage units, 95 percent CI 2.2 to 5.9), while liver fat, the other primary outcome, did not differ. LDL cholesterol fell 0.25 mmol/L relative to control. Triglycerides, HDL cholesterol, glucose, insulin, blood pressure, body composition and 24 hour heart rate variability did not differ.
Randomized, investigator-blinded parallel trial; raw almonds providing 20 percent of daily energy or a calorie-matched snack for 16 weeks; registered NCT02954315 with change in wrinkle depth as the primary outcome, while the paper reports wrinkle severity and width; supported in part by the Almond Board of California and USDA (Foolad et al. 2019, Phytother Res)
31 generally healthy postmenopausal women with Fitzpatrick skin types I and II enrolled at UC Davis; 28 completed.
On standardized photographic analysis, wrinkle severity and wrinkle width were 9 and 10 percent lower in the almond group than in the control group at 16 weeks (p < 0.02). Transepidermal water loss did not differ (p = 0.65), and no adverse effects were reported. A 24 week follow-up trial by the same group reported only changes from baseline.
Randomized crossover trial without masking; 2 oz a day of raw almonds or isocaloric unsalted pretzels for 8 weeks each, 4 week washout, then a 30 minute downhill run and 3 days of recovery; registered NCT04787718 after the trial began, with vigor and VO2max as primary outcomes that this paper does not report; funded by the Almond Board of California (Rayo et al. 2024, Curr Dev Nutr)
26 healthy, mildly overweight adults, average age 37, at San Diego State University, USA.
Pain during maximal contraction was 37 and 33 percent lower with almonds at 24 and 48 hours, and flexion torque was 12 and 9 percent higher at 24 and 72 hours. Creatine kinase fell from its peak by 72 hours only after almonds. Vertical jump force, C-reactive protein, myoglobin and total antioxidant capacity did not differ between trials.
Randomized controlled trial; a 3 month energy-restricted diet (30 percent below needs) containing almonds or carbohydrate-rich nut-free snacks, then a weight maintenance phase; registered ACTRN12618001861246; Europe PMC lists the Almond Board of California as the grant funder (Carter et al. 2023, Obesity (Silver Spring))
140 adults aged 25 to 65 with BMI 27.5 to 34.9; 68 on the almond diet and 72 on the nut-free diet.
Both groups lost 7.0 kg in the first phase (p = 0.858). Fasting glucose, insulin, blood pressure and total and LDL cholesterol improved in both groups by the end of the maintenance phase. Some lipoprotein subfractions changed differently: very small triglyceride-rich and small LDL particles fell more on almonds, and medium LDL particles fell more on the nut-free diet.
Randomized, controlled parallel trial; almonds or isocaloric carbohydrate-rich snacks providing 15 percent of energy for 12 weeks; a working memory composite was the primary outcome; registered ACTRN12615001294549; funded by the Almond Board of California (Coates et al. 2020, Nutrients)
128 adults aged 50 to 80 with overweight or obesity in South Australia; 63 on almonds and 65 on the nut-free diet.
Working memory, the primary outcome, and other cognitive and mood measures did not differ between diets. Triglycerides and systolic blood pressure fell more with almonds, while total, LDL and HDL cholesterol, glucose, insulin, arterial stiffness and body composition did not change.
Three-arm randomized controlled parallel trial; 56 g a day of whole almonds, 56 g a day of ground almonds or isocaloric muffins in place of usual snacks for 4 weeks; fecal bifidobacteria was the primary outcome; registered NCT03581812; supported by an Almond Board of California grant (Creedon et al. 2022, Am J Clin Nutr)
87 healthy adults with low fiber intake at King's College London, UK; 79 analyzed.
Fecal bifidobacteria did not differ among groups (q = 0.613). Fecal butyrate was higher with almonds than control (24.1 versus 18.2 micromol/g, P = 0.046). Gut transit time, stool consistency, microbiota diversity and gut symptoms did not differ, and whole and ground almonds gave the same results.
Multicenter randomized trial of whole diets, corrected and republished in 2018 after protocol deviations in randomization; Mediterranean diet with extra-virgin olive oil, Mediterranean diet with free nuts (walnuts, almonds and hazelnuts), or advice to reduce dietary fat; primary end point major cardiovascular events; ISRCTN35739639; funded by Instituto de Salud Carlos III and others (Estruch et al. 2018, N Engl J Med)
7447 adults in Spain aged 55 to 80, 57 percent women, at high cardiovascular risk without cardiovascular disease at entry; median follow-up 4.8 years.
Major cardiovascular events occurred in 83 people (3.4 percent) on the diet with nuts and 109 (4.4 percent) on the control diet, adjusted hazard ratio 0.72 (95 percent CI 0.54 to 0.95), with similar results after omitting 1588 participants whose assignment departed from protocol. The nut arm combined dietary education with several nut types, so the result is not an almond result.
Side effects and drug interactions
Common Potential side effects
Important Drug interactions
Frequently asked questions about Almond (Prunus dulcis)
How many almonds were used in the studies?
Most trials gave 56 to 57 g a day (about 2 ounces) or enough almonds to supply 15 to 20 percent of daily energy, usually in place of snacks with the same calories. The FDA qualified claim for nuts refers to 1.5 ounces a day. Per 100 g, USDA lists 579 kcal, so the trials swapped almonds for other foods rather than adding them.
What can an almond label say about the heart?
FDA will consider enforcement discretion for this qualified claim: "Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts [, such as name of specific nut,] as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease." Whole or chopped nuts must add "See nutrition information for fat content." Nut-containing products need at least 11 g of qualifying nuts per reference amount customarily consumed and must meet the low saturated fat and low cholesterol definitions.
Do almonds help with weight?
Not beyond their calories. On a 30 percent reduced-calorie diet, adults lost 7.0 kg whether they snacked on almonds or carbohydrate-rich foods. A pooled analysis of 37 trials found 0.45 kg less weight with almonds overall, a difference seen in trials against nut-free diets but not in trials against other snacks or nuts.
Are almond flour and almond butter the same as whole almonds?
Almond flour is ground almonds. In a 4 week trial, 56 g a day of ground almonds gave the same gut results as whole almonds and released slightly more fat on chewing (10.4 versus 9.3 percent predicted). Almond butter and almond protein powder were not tested in the trials cited here.
Who should avoid almonds?
Anyone who has reacted to almonds or other tree nuts. FDA lists tree nuts among the nine major food allergens, and reactions can be severe. People watching calories can still use almonds by swapping them for other snacks, as the trials did.
What is Almond?
Almonds are the edible seeds of Prunus dulcis, eaten whole and sold as almond flour (ground almonds), almond butter and almond protein. Per 100 g, USDA lists about 50 g of fat, mostly monounsaturated, plus 21 g of protein, 12.5 g of fiber and 25.6 mg of vitamin E.
What is Almond used for?
NutraSmarts does not list Almond under a health category. What the research covers: A pooled analysis of 16 randomized trials (1,128 people) found diastolic pressure 1.30 mmHg lower with almonds, while systolic pressure did not change significantly.
What is the recommended dosage of Almond?
The clinically studied dose is 56 to 57 g a day (about 2 ounces) or 15 to 20 percent of daily energy as whole or ground almonds for 4 to 24 weeks, usually in place of snacks of equal calories. The FDA qualified nut claim refers to 1.5 ounces a day of most nuts. Always follow the product label and check with a healthcare provider for personal advice.
Is Almond safe, and does it have side effects?
Side effects and cautions reported for Almond include: Allergy: tree nuts, including almonds, are one of the nine major food allergens in the US, and labels must name the type of tree nut. Reactions range from hives and lip swelling to life-threatening anaphylaxis. Avoid almonds and almond products if you have reacted to them. It may also interact with some medications. Almond is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.
Does Almond interact with any medications?
Possible interactions include: Lipid-lowering and blood pressure medicines: almonds lowered LDL cholesterol by about 0.13 mmol/L and diastolic pressure by about 1.3 mmHg in pooled trials. Do not use almonds in place of prescribed treatment or change a dose on your own. If you take prescription medication, check with a pharmacist or doctor before using it.
How strong is the scientific evidence for Almond?
NutraSmarts rates the evidence for Almond as Limited (2 out of 5). It is backed by 7 study summaries and 16 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.
References(16 citations)
Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.
- Blood Lipid Levels in Response to Almond Consumption: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2025;17(17):2791. doi: 10.3390/nu17172791.PubMedUsed to support: Meta-analysis of randomized trials lasting at least 4 weeks in adults without cardiovascular disease, with nut-free controls: 36 publications (48 almond-control datasets, 2485 participants). Almonds lowered LDL cholesterol by 0.132 mmol/L, total cholesterol by 0.160 mmol/L, non-HDL cholesterol by 0.204 mmol/L and ApoB by 4.55 mg/dL; triglycerides fell only borderline (p = 0.085) and HDL cholesterol, ApoA and Lp(a) did not change. Pooling all 46 LDL strata showed substantial heterogeneity. The authors work for a consultancy paid by the Almond Board of California, which funded the work. A pooled analysis, not a new trial.
- The effect of almond intake on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;50:102399. doi: 10.1016/j.ctim.2020.102399.PubMedUsed to support: Meta-analysis of 16 randomized trials (1128 participants) of almond intake. Diastolic blood pressure was 1.30 mmHg lower (95 percent CI -2.31 to -0.30, I2 = 0 percent), while systolic blood pressure did not change significantly (-0.83 mmHg, 95 percent CI -2.55 to 0.89, I2 = 58.9 percent). The abstract does not describe the control diets of the included trials, and the paper's reference list includes trials that added almonds to habitual or step 1 diets without calorie matching, a peanut versus almond trial and a trial of baru almond (Dipteryx alata, a different plant), so which comparators entered the blood pressure pool could not be confirmed (full text not open access). A pooled analysis, not a new trial.
- Almond supplementation on appetite measures, body weight, and body composition in adults: A systematic review and dose-response meta-analysis of 37 randomized controlled trials. Obes Rev. 2024;25(5):e13711. doi: 10.1111/obr.13711.PubMedUsed to support: Meta-analysis of 37 randomized trials (43 arms). Almonds were linked to slightly lower body weight (-0.45 kg), waist circumference (-0.66 cm), fat mass (-0.66 kg) and hunger scores, with no significant change in BMI, body fat percent, fullness or desire to eat; GRADE certainty was moderate for weight and very low for several other measures. Body weight and waist fell in trials using a nut-free diet as control, but not in trials comparing almonds with other snacks or other nuts. A pooled analysis, not a new trial.
- The effect of almond intake on glycemic control: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2022;36(1):395-414. doi: 10.1002/ptr.7328.PubMedUsed to support: Meta-analysis of 24 studies (31 arms) of almond intake in adults. Almonds did not significantly change fasting blood sugar, HbA1c, insulin or HOMA-IR, and the authors conclude there is no convincing evidence of a clear effect on glycemic control. A pooled analysis, not a new trial.
- Almonds vs. carbohydrate snacks in an energy-restricted diet: Weight and cardiometabolic outcomes from a randomized trial. Obesity (Silver Spring). 2023;31(10):2467-2481. doi: 10.1002/oby.23860.PubMedUsed to support: Abstract read. Randomized trial in adults aged 25 to 65 with overweight or obesity: a 3 month energy-restricted (minus 30 percent) diet containing almonds (n = 68) or carbohydrate-rich nut-free snacks (n = 72), followed by a weight maintenance phase. Weight loss was the same in both groups (7.0 kg each, p = 0.858), and glucose, insulin, blood pressure, total and LDL cholesterol improved in both; some lipoprotein subfractions changed differently between groups. Registered ACTRN12618001861246; Europe PMC lists the Almond Board of California as the grant funder.
- Snacking on whole almonds for 6 weeks improves endothelial function and lowers LDL cholesterol but does not affect liver fat and other cardiometabolic risk factors in healthy adults: the ATTIS study, a randomized controlled trial. Am J Clin Nutr. 2020;111(6):1178-1189. doi: 10.1093/ajcn/nqaa100.PubMedUsed to support: ATTIS: 6 week randomized parallel trial in adults aged 30 to 70 at above-average cardiovascular risk; whole roasted almonds (n = 51) or isoenergetic control snacks matching average UK snack macronutrients (n = 56), each 20 percent of energy needs. Of the two primary outcomes, flow-mediated dilation rose more with almonds (mean difference 4.1 percentage units, 95 percent CI 2.2 to 5.9) while liver fat did not differ. LDL cholesterol fell 0.25 mmol/L relative to control; blood pressure, triglycerides, HDL, glucose, insulin and body composition did not differ. Registered NCT02907684; funded by the Almond Board of California and the Indonesia Endowment Fund for Education, with almonds supplied by the Almond Board.
- Effect of a 12-Week Almond-Enriched Diet on Biomarkers of Cognitive Performance, Mood, and Cardiometabolic Health in Older Overweight Adults. Nutrients. 2020;12(4):1180. doi: 10.3390/nu12041180.PubMedUsed to support: Randomized 12 week trial in 128 adults aged 50 to 80 with overweight or obesity: almonds or isocaloric carbohydrate-rich snacks providing 15 percent of energy. The primary outcome, a working memory composite, did not differ, nor did mood. Triglycerides and systolic blood pressure fell more with almonds, while total, LDL and HDL cholesterol, glucose, insulin and body composition did not change. Registered ACTRN12615001294549; funded by the Almond Board of California; one author has consulted for Nuts for Life, an Australian tree nut industry initiative.
- Prospective randomized controlled pilot study on the effects of almond consumption on skin lipids and wrinkles. Phytother Res. 2019;33(12):3212-3217. doi: 10.1002/ptr.6495.PubMedUsed to support: Investigator-blinded randomized trial in healthy postmenopausal women with Fitzpatrick skin types I and II (31 enrolled, 28 completed): almonds providing 20 percent of daily energy or a calorie-matched snack for 16 weeks. On photographic analysis, wrinkle severity and wrinkle width were 9 and 10 percent lower than in the control group at 16 weeks (p < 0.02); transepidermal water loss did not differ (p = 0.65) and no adverse effects were reported. Registered NCT02954315 (registry lists no masking) with change in wrinkle depth as the primary outcome, which the paper measured but does not report; supported in part by the Almond Board of California and USDA.
- Prospective Randomized Controlled Trial on the Effects of Almonds on Facial Wrinkles and Pigmentation. Nutrients. 2021;13(3):785. doi: 10.3390/nu13030785.PubMedUsed to support: Follow-up 24 week randomized trial in postmenopausal women with Fitzpatrick skin types I and II (56 randomized, 49 completed): almonds providing 20 percent of energy or a calorie-matched snack that was not macronutrient matched. Wrinkle severity fell 15 and 16 percent from baseline at weeks 16 and 24 and facial pigment intensity 20 percent in the almond group, with no improvement in the control group; the paper reports these as changes from baseline rather than a between-group test. Hydration and water loss did not differ. Registered NCT03729700 (primary outcome wrinkle severity at 24 weeks); funded by the Almond Board of California.
- Almond Consumption Modestly Improves Pain Ratings, Muscle Force Production, and Biochemical Markers of Muscle Damage Following Downhill Running in Mildly Overweight, Middle-Aged Adults: A Randomized, Crossover Trial. Curr Dev Nutr. 2024;8(9):104432. doi: 10.1016/j.cdnut.2024.104432.PubMedUsed to support: Randomized crossover trial in 26 healthy adults (average age 37): 2 oz a day of raw almonds or isocaloric unsalted pretzels for 8 weeks each with a 4 week washout, then a 30 minute downhill run and 3 days of recovery. Pain during maximal contraction was lower with almonds at 24 and 48 hours (37 and 33 percent between trials), flexion torque was higher at 24 and 72 hours, and creatine kinase fell from its peak by 72 hours only after almonds; vertical jump force, C-reactive protein, myoglobin and antioxidant capacity did not differ. Registered NCT04787718 (first submitted in March 2021, after the July 2020 start) with vigor and VO2max as primary outcomes, which this paper does not report. Funded by the Almond Board of California, which supplied the almonds.
- The impact of almonds and almond processing on gastrointestinal physiology, luminal microbiology, and gastrointestinal symptoms: a randomized controlled trial and mastication study. Am J Clin Nutr. 2022;116(6):1790-1804. doi: 10.1093/ajcn/nqac265.PubMedUsed to support: Three-arm randomized trial in 87 healthy adults (79 analyzed): 56 g a day of whole almonds, 56 g a day of ground almonds (almond flour) or an isocaloric muffin control in place of usual snacks for 4 weeks. The primary outcome, fecal bifidobacteria, did not differ (q = 0.613). Fecal butyrate was higher with almonds (24.1 versus 18.2 micromol/g, P = 0.046), while gut transit time, stool consistency, microbiota diversity and gut symptoms did not differ, and whole versus ground form made no difference. Ground almonds gave slightly higher predicted lipid release after chewing (10.4 versus 9.3 percent). Registered NCT03581812; supported by an Almond Board of California grant, which also supplied the almonds.
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018;378(25):e34. doi: 10.1056/NEJMoa1800389.PubMedUsed to support: PREDIMED, corrected and republished after the 2013 report was withdrawn over randomization deviations: 7447 adults aged 55 to 80 at high cardiovascular risk in Spain were assigned to a Mediterranean diet with extra-virgin olive oil, a Mediterranean diet with nuts, or advice to reduce dietary fat. Major cardiovascular events occurred in 3.4 percent of the nut group versus 4.4 percent of controls (adjusted hazard ratio 0.72, 95 percent CI 0.54 to 0.95), with similar results after omitting 1588 participants whose assignment departed from protocol. This was a whole-diet intervention with education, so the result cannot be credited to almonds or to nuts alone. Funded by Instituto de Salud Carlos III and others; ISRCTN35739639.
- Influence of a Mediterranean Dietary Pattern on Body Fat Distribution: Results of the PREDIMED-Canarias Intervention Randomized Trial. J Am Coll Nutr. 2016;35(6):568-580. doi: 10.1080/07315724.2015.1102102.PubMedUsed to support: One-year results from 351 PREDIMED participants in the Canary Islands; the abstract identifies the nuts in the Mediterranean diet with nuts arm as walnuts, almonds and hazelnuts, with energy intake ad libitum. No between-group differences in body weight, waist or body composition changes were found among the olive oil, nut and low-fat control diets.
- Qualified Health Claims: Letter of Enforcement Discretion, Nuts and Coronary Heart Disease (Docket No. 02P-0505). U.S. Food and Drug Administration. 2003;Letter dated July 14, 2003; archived FDA page, accessed 2026..SourceUsed to support: Not PubMed-indexed; FDA letter read via its archived page, which FDA's current qualified health claims index links to. In response to a petition from the International Tree Nut Council Nutrition Research and Education Foundation covering peanuts and nine tree nuts including almonds (FDA excluded Brazil nuts, macadamia nuts, cashews and some pine nuts as exceeding saturated fat disqualifying levels), FDA will consider enforcement discretion for the qualified claim: "Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts [, such as name of specific nut,] as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease. [See nutrition information for fat content.]" The fat-content disclosure applies to whole or chopped nuts; nut-containing products must contain at least 11 g of qualifying nuts per reference amount customarily consumed (RACC) and meet the low saturated fat and low cholesterol definitions.
- Food Allergies. U.S. Food and Drug Administration. 2026;Web page, content current as of 03/11/2026..SourceUsed to support: Not PubMed-indexed; FDA consumer page read in 2026. Lists the nine major food allergens (milk, eggs, fish, Crustacean shellfish, tree nuts, peanuts, wheat, soybeans and sesame) under FALCPA and the FASTER Act, states that labels must name the type of tree nut (for example, almonds, pecans, walnuts), and notes that reactions range from hives and lip swelling to life-threatening anaphylaxis.
- FoodData Central: Nuts, almonds (SR Legacy, FDC ID 170567). USDA FoodData Central. 2019;SR Legacy food 12061..SourceUsed to support: Not PubMed-indexed; USDA nutrient database entry read via the FoodData Central API. Per 100 g of almonds: 579 kcal, 21.15 g protein, 49.93 g fat (31.55 g monounsaturated, 12.33 g polyunsaturated, 3.80 g saturated), 21.55 g carbohydrate, 12.5 g dietary fiber, 25.63 mg vitamin E (alpha-tocopherol), 270 mg magnesium, 269 mg calcium and 733 mg potassium.